首页> 外国专利> ‡ nucleic acid, nucleic acid molecule, probe, recombinant expression vector, cell, processes to produce a h polypeptide. pylori and to detect the presence of a helicobacter pylori nucleic acid in a sample, h. pylori isolated, cell, cellular and secreted envelope polypeptides from h. pylori or its fragments, fusion protein, vaccine formulation for the prophylaxis or treatment of an infection by h. pylori, and, processes to treat or reduce a risk of infection by h. pylori in a subject and to produce a vaccine formulation.

‡ nucleic acid, nucleic acid molecule, probe, recombinant expression vector, cell, processes to produce a h polypeptide. pylori and to detect the presence of a helicobacter pylori nucleic acid in a sample, h. pylori isolated, cell, cellular and secreted envelope polypeptides from h. pylori or its fragments, fusion protein, vaccine formulation for the prophylaxis or treatment of an infection by h. pylori, and, processes to treat or reduce a risk of infection by h. pylori in a subject and to produce a vaccine formulation.

机译:‡核酸,核酸分子,探针,重组表达载体,细胞,产生h多肽的过程。并检测样品中是否存在幽门螺杆菌核酸; h。来自h的幽门螺杆菌分离的,细胞,细胞和分泌的包膜多肽幽门螺杆菌或其片段,融合蛋白,疫苗制剂,用于预防或治疗h感染。幽门螺杆菌,以及治疗或降低h感染风险的方法。幽门螺杆菌在受试者体内并产生疫苗制剂。

摘要

"NUCLEIC ACID, NUCLEIC ACID MOLECULE, PROBE, RECOMBINANT EXPRESSION VECTOR, CELL, PROCESSES TO PRODUCE A POLYPEPTIDE OF H. PYLORI AND TO DETECT THE PRESENCE OF A NUCLÉIC ACID OF HYORACLE, PILOT OF HELICOLE H. PYLORI CELL, CELLULAR AND SECRET SECRETARY ENVELOPE POLYPEPTIDS OR ITS FRAGMENTS, FUSION PROTEIN, VACCINE FORMULATION FOR PROPHYLAXIS OR TREATMENT OF AN INFECTION BY H. PYLORI, AND PROCESSES TO TREAT REDUCING HYDRO OR REDUCING HYDRO REDUCING PROTECTION. . PYLORI IN A SUBJECT AND TO PRODUCE A VACCINE FORMULATION ". Recombinant or substantially pure preparations of H. pylori polypeptides are described. Nucleic acids encoding polypeptides are also described. H. pylori polypeptides are useful for diagnostics and vaccine compositions.
机译:“核酸,核酸分子,探针,重组表达载体,细胞,可生产幽门螺杆菌的多肽,并检测出杯状核酸,螺旋形螺鞘和细胞核的壳,细胞核多肽或片段,融合蛋白,用于丙酸杆菌的疫苗制剂或幽门螺杆菌的感染治疗,以及处理还原水合物或还原水还原保护的方法。……………………………………………………………………………………………………………………………………………………………………………………………………………………………………描述了幽门螺杆菌多肽的重组或基本上纯的制剂。还描述了编码多肽的核酸。幽门螺杆菌多肽可用于诊断和疫苗组合物。

著录项

  • 公开/公告号BR9712587A

    专利类型

  • 公开/公告日1999-10-26

    原文格式PDF

  • 申请/专利权人 ASTRA AKTIEBOLAG;

    申请/专利号BR19979712587

  • 发明设计人 DOUGLAS SMITH;RICHARD A. ALM;

    申请日1997-10-28

  • 分类号A01N43/04;A61K31/70;C12Q1/68;

  • 国家 BR

  • 入库时间 2022-08-22 02:28:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号